Fulgent Genetics, Inc. (FLGT)
Fulgent Genetics Market Cap : 501.22M for April 6, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Delcath Systems, Inc. | 339.49M |
| Quest Diagnostics, Inc. | 21.98B |
| CytoSorbents Corp. | 37.44M |
| Cardiac Biotech Solutions, Inc. | 4.963M |
| Odyssey Health, Inc. | 6.271M |
Market Cap Related Metrics
| PS Ratio | 1.531 |
| PEG Ratio | -0.2100 |
| Price to Book Value | 0.4508 |
| Price | 16.42 |
| Earnings Yield | -12.25% |
| PEGY Ratio | -0.2100 |